A safety study of PIEZO-101 for skin laxity in knees and décolleté
Treatments studied
Part of Skin clinical trials.
This early-phase trial tests a new treatment, PIEZO-101, for skin laxity, wrinkling, or crepiness in the knee and upper chest (décolleté) areas. It aims to assess safety and early signs that the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Healthy women aged 40 to 65 years
- Have visible skin looseness, wrinkles, or fine lines on the knees and upper chest
- Willing to have small skin samples (biopsies) taken from the knee area
- Must avoid other aesthetic or skin treatments in the treated areas during the study
- Able to attend 10 study visits over 90 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new aesthetic device called Cellbooster Shape can safely reduce signs of facial aging, like loose skin and puffiness under the chin or cheeks, in healthy adults. The device uses a procedure similar to other cosmetic treatments.
This trial tests a micro-coring device called Ellacor® to improve both facial wrinkles and abdominal skin looseness. It is open to people of all skin types and includes those taking certain diabetes/weight-loss medications (GLP-1 agonists).
This trial tests two treatments called INNEA and INNEA AQUA for cheek and décolletage wrinkles. The goal is to see how well they work and if they are safe for women aged 35-65.
This study tests whether injections of poly-L-lactic acid (a collagen-boosting filler) can improve loose skin on the belly in women taking or not taking GLP-1 medications (like Ozempic or Wegovy). It aims to help people who have mild to moderate loose skin and are at a stable weight.
This study tests a polynucleotide-based injection to improve skin hydration in one area of the face, neck, or chest. It may be an option if you have healthy skin and are looking for a non-surgical way to boost moisture.
This trial tests whether a hyaluronic acid filler (a gel injected into the skin) can improve skin quality in women who are taking or not taking GLP-1 medications (like Ozempic or Wegovy). It aims to see if the filler helps with skin radiance, elasticity, tone, firmness, fine lines, wrinkles, and smoothness.
Hear when a new Skin Aging trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.